Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Post by vitalina2233on Apr 27, 2021 1:12pm
196 Views
Post# 33075098

response

responseHi XXXXXX
 
The company filed a NASDAQ application in January 2021 and are working to meet all the requirements set by the exchange. We hope to update our valued shareholders in the near future.



Best,
 
On Tue, Apr 27, 2021 at 9:30 AM Ernesto DiSalvo <f> wrote:
Hi Charles, hope your well. Investors are eagerly awaiting the next move to the Naz. Is their anything you can share with us  at this time. I seen a stock in our space on the Naz up over 800% this year ,sorry can’t recall the name. Any info would be helpful as you see we have penny flippers out there that are bashing the stock  Thanks
 
Sent from Mail for Windows 10
 
--
 
Charles Lee
Investor Relations,  Mydecine Innovations Group Inc.
+1 (720) 277-9879 | clee@mydecineinc.com
www.mydecine.com 
 
| NEO Symbol: MYCO
 
 

<< Previous
Bullboard Posts
Next >>